Stock Price: Oragenics, Inc. (OGEN)

Oragenics, Inc. (OGEN) possesses significant market influence due to its unique intranasal delivery of neuroprotectors for treating brain injuries, rendering demand highly inelastic. This chart reflects an asset value of 0.20. Stringent FDA requirements and patent protection create formidable barriers to entry, while the brand's impeccable scientific image attracts venture capitalists.

OGEN - Oragenics Market Price over the range 07/04/2022 - 11/14/2026

Oragenics - analytical breakdowns and key metrics (OGEN)

- stock value and consensus price forecast:

Price Chart oragenics.com|OGEN - Average Forecast Price

- company stock exchange capitalization indicators:

Market Capitalization Oragenics, Inc.|OGEN - Full Takeover Company Value

- book capitalization information:

Book Value per Share Oragenics|OGEN - Total Stockholders' Equity|Market Value to Book Value Ratio oragenics.com|OGEN - Total Business Assets

- debt and liquidity data:

- earnings and market ratios statistics:

OGEN - Net Income|Projected Future Earnings Oragenics, Inc.|OGEN - P/E Multiple|Projected Price to Earnings Oragenics, Inc.|OGEN - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Oragenics, Inc.|OGEN - Operating income before deduction of amortization|Earnings per share for the last twelve months Oragenics|OGEN - Earnings per share for the last 12 months|Quarterly EPS earnings growth oragenics.com|OGEN - Earnings per share trend in current year|Earnings growth forecast for next year Oragenics, Inc.

- sales and revenue data:

OGEN - Company Total Revenue|Projected Sales Volume oragenics.com|OGEN - Market Cap to Revenue|Forward Price-to-Revenue Multiple Oragenics Inc.

Fundamental valuation:oragenics.com

To minimize investment risks, it is essential to assess the resilience of Oragenics, Inc. (OGEN) quotes to market shocks, particularly during the commercialization phase of intranasal vaccines and treatments for neurological pathologies. By analyzing changes in market value, an investor determines the asset's ability to retain capital during broad sell-offs, which allows for the differentiation of the company's fundamental strength from temporary macroeconomic pressure and forced liquidations.

Analysis of competing companies